India’s New Patent Regime: Impact On Global Pharmas
March 6, 2008, 12:00 AM EST
Law360, New York (March 6, 2008, 12:00 AM EST) -- It has been more than three years since the Indian Parliament passed the latest amendments to the India Patents Act of 1970 aimed at conforming India’s patent laws to the requirements set forth by the World Trade Organization's (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
TRIPS sets down minimum standards for many forms of intellectual property protection that its member countries must provide. Notably, the new amendments allow for product patent protection for pharmaceuticals.
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.